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Leprosy is a chronic infectious disease of M. leprae that causes damage to the skin and nerves. 
Indonesia is one of the countries which is the endemic areas of leprosy, the prevalence of leprosy continues to 
increase. The immune response not only determines the type of leprosy that will manifest to individual, but 
also determines an individual's susceptibility to leprosy. One of the cytokines that play an important role in the 
pathogenesis of leprosy is interleukin-10 (IL-10), which works on active macrophages to end the response to 
microbes and return the system to rest when the microbes are destroyed. Increased regulation of IL-10 can 
affect the decrease in macrophage activity in killing bacteria. Polymorphism of -819 is thought to influence the 
expression of IL-10 genes. This study aims to identify the polymorphism of the -819 of the interleukin-10 
promoter gene in leprosy patients treated at RSUP dr. Mohammad Hoesin Palembang. This research is an 
observational descriptive study with cross sectional design. Polymorphism of the -819 of the interleukin-10 
promoter gene was measured by the PCR-RFLP method, electrophoresis, and visualized in UV light. From this 
study, the frequency distribution of TT genotypes is 42%, CT is 44%, and CC is 14%. The frequency 
distribution of T allele is 32% and C allele is 18%. Wild type genotype description is more common in leprosy 
sufferers (80%). 
  




Leprosy is a chronic infectious disease of 
M. leprae which causes damage to the skin and 
nerves which can result in disability. 
Disabilities in leprosy sufferers causes work 
productivity to decrease so that it greatly affects 
the quality of life for people with leprosy. 
Leprosy creates a big stigma in society, so that 
people with leprosy are often shunned and 
ostracized by the community which causes 
psychosocial problems (Direktorat Jendral 
P2PL Kemenkes RI, 2012). 
The prevalence of leprosy continues to 
increase, especially in Indonesia, which is one 
of the leprosy endemic areas. The World Health 
Assembly (WHA) made a resolution on the 
elimination of leprosy in 2000 by reducing the  
 
 
prevalence of leprosy to below 1 case per 
10,000 population. This resolution in Indonesia 
is known as Eliminasi Kusta Tahun 2000 (EKT 
2000). Although Indonesia has achieved the 
national elimination target, 14 regions of 
Indonesia, especially the eastern part, are still 
areas with a high burden of leprosy with a new 
case finding rate of ≥10 per 100,000 (Depkes 
RI, 2005). 
The previous hypothesis stated that the 
main factor that causes leprosy is the source of 
infection (Prawoto, 2008). This opinion is not 
entirely correct because in some individuals 
exposure to M. leprae does not cause leprosy. 
This then led some researchers to be interested 
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in studying the role of the immune response in 
leprosy (Alter, et al., 2011). 
One of the cytokines believed to play an 
important role in the pathogenesis of leprosy is 
interleukin-10 (IL-10). Interleukin-10 is an 
immune system cytokine (immunoregulator) 
produced by Th2 cells, Th3 cells, monocytes, 
dendritic cells, eosinophils, mast cells, and 
keratinocytes. Phagocytosis by macrophages is 
the main immune response to the elimination of 
M. leprae because the bacteria live 
intracellularly. Interleukin-10 acts on active 
macrophages to end the response to microbes 
and return the system to a resting state after the 
microbes have been destroyed. Increased 
regulation of IL-10 can have an effect on 
decreasing the activity of macrophages in 
killing bacteria (Sari, et al., 2013). 
The IL-10 gene is located on 
chromosome 1q32. The presence of 
polymorphisms in these genes is thought to 
cause changes in the expression of the IL-10 
gene produced, which can then affect the 
process of microbial elimination in the 
development of leprosy (Cardoso, et al., 2011). 
 
2. METHODS 
 This research is a descriptive 
observational laboratory study with a cross-
sectional study approach, to observe and 
present the results of observations on the IL-10 
gene using PCR-RFLP in leprosy patients. 
Sampling was carried out at dr. Mohammad 
Hoesin Palembang. Sample processing includes 
DNA extraction and PCR-RFLP, carried out at 
the Biotechnology Laboratory of Medical 
Faculty, Universitas Sriwijaya. 
 Blood samples were taken through 3 ml 
of antecubital vein punctures and put into a tube 
containing ethylene diamine tetra acid (EDTA) 
anticoagulant for DNA extraction and PCR. 
The sample used in this study were all patients 
diagnosed with leprosy by doctors and treated 
at dr. Mohammad Hoesin Palembang for the 
period January-February 2019. 
 DNA isolation was carried out using 
Qiagen DNA extraction kit according to the 
procedure listed on the kit. 
 The primary sequences used were 5'-
AGACAACACTACTAAGGCTTCTTGAGG
A-3 'for IL 10 F (forward) primers and 5'-
AGGTAGTGCTCACCATGACC-3' primers 
for IL 10 R (reverse) primers. The specificity of 
the two primers was confirmed by 'BLAST' via 
the official website 
http://www.ncbi.nlm.nih.gov. The 
confirmation results showed that both primers 
were specific for IL-10 gene amplification (-
819 C/T). The composition of the mixture with 
a total volume of 25 μl that was used when 
carrying out PCR consisted of 10 μl of Go Taq 
PCR mix (Promega, USA), 12 μl ddH2O, and 2 
μl of printed DNA (template), as well as reverse 
(R) and forward (F) oligonucleotide primers,  
0.5 μl each. 
 The process of DNA synthesis takes place 
in three repeated reaction stages of 35 cycles at 
different temperatures, namely the denaturation 
reaction at 950C for 10 minutes to separate the 
double chain into two single chains, the 
annealing reaction is the reunification of the 
two DNA chains which takes place at 940C for 
30 seconds, 580C for 30 seconds, 720C for 45 
seconds and extension, namely DNA synthesis 
by extension of a primer following its single-
chain DNA nucleotide sequence which 
generally takes place at 720C for 7 minutes. The 
quality of DNA amplified by PCR technique 
was seen using agarose gel electrophoresis 
technique (2% concentration). The DNA 
marker 100bp was used as a marker for the size 
of the DNA bands from electrophoresis. The gel 
was electrophoresed at 100 volts for 30 
minutes. 
 The IL-10 gene polymorphisms were 
determined by PCR-RFLP analysis. The IL-10 
gene polymorphism detection was carried out 
by cutting the DNA of PCR products with the 
restriction enzyme MsII. This will cause the 
formation of new restriction sites that can be 
recognized by the restriction enzymes. A total 
of 0.25 µL of enzyme was added to the 
eppendorf tube containing 15.5 µL of PCR 
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product, then it was cortexed for a few seconds 
and incubated in a water bath at 37oC for 1 
hour. After digestion, the PCR product was 
electrophoresed at 3% agarose gel and analyzed 
by staining with ethidium bromide, using a 




A total of 50 people with leprosy 
participated in this study. The frequency of 
male subjects was 33 people, while women 
were 17 people. The mean age was 42.08 ± 
14.65 years. The frequency of the Malay race is 
49 people, while the frequency of the non-
Malay race is 1 person. The most frequent type 
of leprosy (WHO classification) is the 
multibacillary type (MB), which is 46 people 
(92%). The frequency of papalibacillary type 
(PB) was 4 people (8%). 
PCR results of the -819 Interleukin-10 
promoter gene were seen at the 359 bp position. 
After the PCR stage is complete, the research is 
continued with Restriction Fragment Length 
Polymorphism (RFLP), which is the restriction 
stage using the MslI enzyme, which is carried 
out by mixing the PCR product (amplicon) with 
the MslI enzyme and incubating at 37oC for 1 
hour. There are 3 types of genotypes that can be 
identified from gene polymorphisms, namely 
wild type genotypes, polymorphic 
heterozygous genotypes, and polymorphic 
homozygous genotypes. The wild type 
genotype is a common genotype that is often 
found in genes without polymorphisms. This 
type of genotype is TT. Polymorphic 
heterozygous genotype is a genotype produced 
when there is a change from one base T to C so 
that the resulting genotype is CT. The 
polymorphic homozygous genotype is the 
genotype produced when the two bases T to C 
change so that the resulting genotype is CC. 
The polymorphism of the -819 
Interleukin-10 promoter of the gene is 
characterized by a variation in the image of the 
allele resulting from the digestion of DNA 
fragments by the restriction enzyme MslI which 
looks like this: 
a. One band appearance at 359 bp shows that 
there was no cutting of the amplicon DNA 
fragment by the MslI enzyme in both alleles, 
which means that the amplicon contains the 
homozygote wild type TT genotype. 
b. Two bands appearance at 65 bp and 294 bp 
show that the amplicon DNA fragment was 
cut by the MslI enzyme in both alleles, 
which means that the amplicon contains the 
polymorphic homozygote genotype type 
CC. 
c. Three bands appearance at 65 bp, 294 bp, 
and 359 bp show that the amplicon DNA 
fragment was cut by the MslI enzyme in one 
of the alleles, which means that the 
amplicon contains a heterozygote 
polymorphic type CT genotype. 
 
In this study, the frequency distribution 
of TT, CT, and CC genotypes in the case groups 
were 21 (42%), 22 (44%), and 7 (14%), 
respectively. The frequency distribution of the 
T allele is 64 (64%), the frequency of the C 
allele is 36 (36%). 
Based on age, the genotypes of TT, CT, 
CC gene IL-10 -819 in the study subjects were 
15 (30%), 17 (34%), 6 (12%) for those aged 
under 50 years, and 6 (12%), 5 (10%), 1 (2%) 
for those aged over 50 years. The T and C 
alleles of IL-10 -819 genes in the study subjects 
were 47 (47%) and 23 (23%) for those aged 
under 50 years, and 17 (17%) and 6 (6%) for 
those aged over 50 years. 
Based on gender, genotypes of TT, CT, 
CC gene IL-10 -819 in study subjects were 16 
(32%), 12 (24%), 5 (10%) in men, and 5 (10%), 
10 (20%), 2 (4%) in women. The T and C 
alleles of the IL-10 -819 gene were 44 (44%) 
and 22 (22%) in men, and 20 (20%) and 14 
(14%) in women. 
Based on disease classification, 
genotypes of TT, CT, CC gene IL-10 -819 
based on study subjects were 18 (36%), 21 
(42%), 7 (14%) for multibacillary, and 3 (6%), 
1 ( 2%), 0 (0%) for paucibacillers. The T and C 
alleles of IL-10 -819 genes were 57 (57%) and 
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35 (35%) for multibacillers, as well as 7 (7%) 
and 1 (1%) for paucibacillers. 
 
4. DISCUSSION 
In this study, the frequency of men was 
33 people (66%) and women were 17 people 
(34%). Research Felix et al (2011) in Mexico 
reported the same thing, the frequency of men 
in the case group was 69% more than 31% of 
women. Malhotra et al (2005) in India also 
reported that the frequency of males is 84% 
more than that of females is 16%. The opposite 
result was reported by Alvarado-Arnez et al 
(2015) in Brazil who stated that the frequency 
of men in the case group was less, 46% 
compared to 54% women. Cardona-Castro et al 
in Colombia (2012) also reported that the 
frequency of males was 28% less than that of 
women 72%. Research conducted by Bakker in 
2006 showed that men have a 22-fold higher 
risk of developing leprosy than women. 
The mean age of the study subjects was 
42.08 ± 14.65 years. Research by Garcia, et al. 
(2015) reported that the mean age was slightly 
higher in the case group, 43.35 ± 1.83 compared 
to the control group, which was 38.39 ± 1.64. 
The study by Santos, et al (2002) reported that 
the mean age in the case group was 49.3 ± 7.3 
and in the control group it was 47.4 ± 4.1. 
Doull's research in 1945 in the 
Philippines states that there is a relationship 
between the risk of getting leprosy clinically 
with the age of initial exposure, the risk 
decreases according to the age of exposure, so 
that age can be a potential risk factor for contact 
persons to develop leprosy. 
In the research subjects, the most 
frequent type of leprosy (WHO classification) 
was the multibacillary type (MB), which was 46 
people (92%). The frequency of paucibacillary 
type (PB) was 4 people (8%). Several 
epidemiological studies state that the incidence 
of multibacillary type / MB leprosy is higher 
than that of paucibacillary / PB. In Ethiopia, for 
example, the incidence of MB leprosy is 90% 
higher than PB which is only 10% (Ramos, et 
al, 2012). Other studies have also stated that 
there is an increase in new cases of MB leprosy 
compared to PB type leprosy (Basel, et al, 
2014). 
The polymorphism that occurs in the 
Interleukin-10 gene promoter which is cut with 
the MslI enzyme is in the form of a common 
allele base change, in this case T (thymine) 
becomes base C (cytosine) at base 819. 
Reference to wild type genotypes is taken from 
a comparison of dominant and codominant 
models, while references to mutant genotypes 
are taken from comparisons of recessive 
models (Madeshiya, et al, 2017). In this study, 
the most common allele found was the T allele 
so that the wild type genotype was TT. Wild 
type (TT) when visualized will show 1 band, 
heterozygous genotype (CT) when visualized 
will show 3 bands, and homozygous mutant 
genotype (CC) when visualized will show 2 
bands in the marker area. 
Changes in TàC at the 819 base of the 
IL-10 gene promoter can affect the transcription 
of mRNA and IL-10 expression. The promoter 
region is a region related to the 5 'flanking 
region. Region 5 'flanking is a region of DNA 
attached to the 5' end of the gene, which 
contains promoters and may contain enhancers 
or other protein binding sites. This region 
primarily functions in the regulation of gene 
transcription. Polymorphisms in this region can 
trigger changes in transcription regulation. 
Changes in transcription can affect the amount 
of IL-10 protein produced. (Trifunovic, et al., 
2014). 
In a study conducted by Santos in 2002, 
the frequency of the genotype 819TT was 
significantly higher in leprosy patients than in 
controls in the Brazilian population. In the 
study case group, analysis of the frequency 
distribution of the IL-10 gene promoter allele 
showed that the -819T allele was significantly 
more prevalent in PB type leprosy patients, in 
whom there was a strong cell-mediated immune 
response. The fact is that several 
polymorphisms in the proximal region of the 
IL-10 promoter can be combined to form a 
haplotype, the most frequently observed being 
associated with high IL-10 production is the 
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haplotype -3575T / -2849G / -2763C / -819T / -
592A. Therefore, it is possible that this IL-10 
haplotype is associated with a patient's 
susceptibility to developing leprosy. In fact in 
the Santos study, in the patient cohort, analysis 
of the frequency distribution of alleles in the IL-
10 promoter gene showed that the IL-10 -819T 
allele was significantly more common among 
patients with the PB form of leprosy, where 
there was a cell-mediated immune response. 
The same thing was also conveyed in the 
research of Pereira (2009) and Alvarado-Arnez 
(2015) which stated that the -819T allele was 
associated with leprosy susceptibility. The 
haplotype of the promoter polymorphism 
carrying the -819T allele also shows 
susceptibility to leprosy. The -819T allele 
carriers showed lower in vitro IL-10 production 
compared with the non-carriers. The study 
showed that low IL-10 production can lead to 
the chronic, unprotected response associated 
with leprosy. 
In contrast to the above statements, 
several studies conducted in various 
populations found different things. The absence 
of a relationship between the IL-10 gene 
promoter -819 point polymorphism and leprosy 
susceptibility to conclusions in some of these 
studies. In parts of the African continent, a 
study conducted by Fitness in 2004 concluded 
that there was no relationship between the point 
-819 polymorphism and leprosy susceptibility. 
In the Mexican population, Felix's research in 
2011 also concluded that there was no 
association of C819T polymorphism with 
lepromatous leprosy in the Mexican population. 
In China, research conducted by Chen in 2013 
stated that the IL-10 gene promoter -819 point 
polymorphism was not associated with leprosy 
susceptibility. 
In the Malawian population it was found 
that the −592 homozygous variant might 
increase susceptibility to leprosy (Fitness, et al, 
2004). Recently, the -819 T variant has been 
reported to be weakly associated with leprosy 
susceptibility in Brazil (Franceschi, 2009; 
Garcia, 2013). These two variants exhibit an 
associated disequilibrium and usually co-occur 
in the haplotypes (−1082A, −819T, −592A) 
which are associated with increased IL-10 
production. In Brazil, homozygosity for the 
−592A variant was not significantly associated 
with susceptibility, but there was a trend in this 
direction. Thus, it is possible that the ATA 
haplotype could be associated with leprosy 





Wild type genotypes are more common in 
people with leprosy. 
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